Abbott (ABT) Reports In-Line Q3 EPS, Offers Q4 Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $95.40 +3.49%
Revenue Growth %: +9.6%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
CRMT, More
Revenue Growth %: +9.6%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q3 EPS of $0.75, in-line with the analyst estimate of $0.75. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.65 billion.
GUIDANCE:
Abbott sees FY2018 EPS of $2.87-$2.89, versus the consensus of $2.89.
Abbott sees Q4 2018 EPS of $0.80-$0.82, versus the consensus of $0.82.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Starts Abbott Labs (ABT) at Outperform, 'Set to Improve with Catalysts Ahead'
- Nike (NKE) Tops Q4 EPS by 8c
- AeroVironment (AVAV) Tops Q4 EPS by 36c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
